-
1
-
-
33748660920
-
Phase III study of craniospinal radiation therapy followed by adjuvant chemotherapy for newly diagnosed average-risk medulloblastoma
-
Packer RJ, Gajjar A, Vezina G, Rorke-Adams L, Burger PC, Robertson PL, et al. Phase III study of craniospinal radiation therapy followed by adjuvant chemotherapy for newly diagnosed average-risk medulloblastoma. J Clin Oncol 2006;24:4202-8.
-
(2006)
J Clin Oncol
, vol.24
, pp. 4202-4208
-
-
Packer, R.J.1
Gajjar, A.2
Vezina, G.3
Rorke-Adams, L.4
Burger, P.C.5
Robertson, P.L.6
-
2
-
-
55949132115
-
Management of and prognosis with medulloblastoma: Therapy at a crossroads
-
Packer RJ, Vezina G. Management of and prognosis with medulloblastoma: therapy at a crossroads. Arch Neurol 2008;65:1419-24.
-
(2008)
Arch Neurol
, vol.65
, pp. 1419-1424
-
-
Packer, R.J.1
Vezina, G.2
-
3
-
-
0032940605
-
Germ-line and acquired mutations of INI1 in atypical teratoid and rhabdoid tumors
-
Biegel JA, Zhou JY, Rorke LB, StenstromC, Wainwright LM, Fogelgren B. Germ-line and acquired mutations of INI1 in atypical teratoid and rhabdoid tumors. Cancer Res 1999;59:74-9.
-
(1999)
Cancer Res
, vol.59
, pp. 74-79
-
-
Biegel, J.A.1
Zhou, J.Y.2
Rorke, L.B.3
Stenstrom, C.4
Wainwright, L.M.5
Fogelgren, B.6
-
4
-
-
0036061877
-
Atypical teratoid/rhabdoid tumor of the central nervous system: Report on workshop
-
Packer RJ, Biegel JA, Blaney S, Finlay J, Geyer JR, Heideman R, et al. Atypical teratoid/rhabdoid tumor of the central nervous system: report on workshop. J Pediatr Hematol Oncol 2002;24:337-42.
-
(2002)
J Pediatr Hematol Oncol
, vol.24
, pp. 337-342
-
-
Packer, R.J.1
Biegel, J.A.2
Blaney, S.3
Finlay, J.4
Geyer, J.R.5
Heideman, R.6
-
5
-
-
0036849922
-
Alterations of the hSNF5/INI1 gene in central nervous system atypical teratoid/rhabdoid tumors and renal and extrarenal rhabdoid tumors
-
Biegel JA, Tan L, Zhang F, Wainwright L, Russo P, Rorke LB. Alterations of the hSNF5/INI1 gene in central nervous system atypical teratoid/rhabdoid tumors and renal and extrarenal rhabdoid tumors. Clin Cancer Res 2002;8:3461-7.
-
(2002)
Clin Cancer Res
, vol.8
, pp. 3461-3467
-
-
Biegel, J.A.1
Tan, L.2
Zhang, F.3
Wainwright, L.4
Russo, P.5
Rorke, L.B.6
-
6
-
-
84863562673
-
Glioblastoma survival in the United States before and during the temozolomide era
-
Johnson DR, O'Neill BP. Glioblastoma survival in the United States before and during the temozolomide era. J Neurooncol 2012;107: 359-64.
-
(2012)
J Neurooncol
, vol.107
, pp. 359-364
-
-
Johnson, D.R.1
O'Neill, B.P.2
-
7
-
-
84860357535
-
Effect of pretreatment clinical factors on overall survival in glioblastoma multiforme: A Surveillance Epidemiology and End Results (SEER) population analysis
-
Thumma SR, Fairbanks RK, Lamoreaux WT, Mackay AR, Demakas JJ, Cooke BS, et al. Effect of pretreatment clinical factors on overall survival in glioblastoma multiforme: a Surveillance Epidemiology and End Results (SEER) population analysis. World J Surg Oncol 2012; 10:75.
-
(2012)
World J Surg Oncol
, vol.10
, pp. 75
-
-
Thumma, S.R.1
Fairbanks, R.K.2
Lamoreaux, W.T.3
Mackay, A.R.4
Demakas, J.J.5
Cooke, B.S.6
-
8
-
-
33747366434
-
Identification and characterization of NYGGF4, a novel gene containing a phosphotyrosine-binding (PTB) domain that stimulates 3T3-L1 preadipocytes proliferation
-
Wang B, Zhang M, Ni YH, Liu F, Fan HQ, Fei L, et al. Identification and characterization of NYGGF4, a novel gene containing a phosphotyrosine-binding (PTB) domain that stimulates 3T3-L1 preadipocytes proliferation. Gene 2006;379:132-40.
-
(2006)
Gene
, vol.379
, pp. 132-140
-
-
Wang, B.1
Zhang, M.2
Ni, Y.H.3
Liu, F.4
Fan, H.Q.5
Fei, L.6
-
9
-
-
77249165764
-
Extensive proteomic screening identifies the obesity-related NYGGF4protein as a novel LRP1-interactor, showing reduced expression in early Alzheimer's disease
-
Kajiwara Y, Franciosi S, Takahashi N, Krug L, Schmeidler J, Taddei K, et al. Extensive proteomic screening identifies the obesity-related NYGGF4protein as a novel LRP1-interactor, showing reduced expression in early Alzheimer's disease. Mol Neurodegener 2010;5:1-11.
-
(2010)
Mol Neurodegener
, vol.5
, pp. 1-11
-
-
Kajiwara, Y.1
Franciosi, S.2
Takahashi, N.3
Krug, L.4
Schmeidler, J.5
Taddei, K.6
-
10
-
-
33847632605
-
Identification of the ligands of protein interaction domains through a functional approach
-
Caratu G, Allegra D, Bimonte M, Schiattarella GG, D'Ambrosio C, Scaloni A, et al. Identification of the ligands of protein interaction domains through a functional approach. Mol Cell Proteomics 2007;6: 333-45.
-
(2007)
Mol Cell Proteomics
, vol.6
, pp. 333-345
-
-
Caratu, G.1
Allegra, D.2
Bimonte, M.3
Schiattarella, G.G.4
D'Ambrosio, C.5
Scaloni, A.6
-
11
-
-
52449119078
-
Integrated genomics identifies five medulloblastoma subtypes with distinct genetic profiles, pathway signatures and clinicopathological features
-
Kool M, Koster J, Bunt J, Hasselt NE, Lakeman A, van Sluis P, et al. Integrated genomics identifies five medulloblastoma subtypes with distinct genetic profiles, pathway signatures and clinicopathological features. PLoS ONE 2008;3:e3088.
-
(2008)
PLoS ONE
, vol.3
-
-
Kool, M.1
Koster, J.2
Bunt, J.3
Hasselt, N.E.4
Lakeman, A.5
Van Sluis, P.6
-
12
-
-
65849356587
-
Beta-catenin status in paediatric medulloblastomas: Correlation of immunohistochemical expression with mutational status, genetic profiles, and clinical characteristics
-
Fattet S, Haberler C, Legoix P, Varlet P, Lellouch-Tubiana A, Lair S, et al. Beta-catenin status in paediatric medulloblastomas: correlation of immunohistochemical expression with mutational status, genetic profiles, and clinical characteristics. J Pathol 2009;218:86-94.
-
(2009)
J Pathol
, vol.218
, pp. 86-94
-
-
Fattet, S.1
Haberler, C.2
Legoix, P.3
Varlet, P.4
Lellouch-Tubiana, A.5
Lair, S.6
-
13
-
-
84864444165
-
Novel mutations target distinct subgroups ofmedulloblastoma
-
Robinson G, Parker M, Kranenburg TA, Lu C, Chen X, Ding L, et al. Novel mutations target distinct subgroups ofmedulloblastoma. Nature 2012;488:43-8.
-
(2012)
Nature
, vol.488
, pp. 43-48
-
-
Robinson, G.1
Parker, M.2
Kranenburg, T.A.3
Lu, C.4
Chen, X.5
Ding, L.6
-
14
-
-
79955034739
-
Medulloblastoma comprises four distinct molecular variants
-
Northcott PA, Korshunov A, Witt H, Hielscher T, Eberhart CG, Mack S, et al. Medulloblastoma comprises four distinct molecular variants. J Clin Oncol 2011;29:1408-14.
-
(2011)
J Clin Oncol
, vol.29
, pp. 1408-1414
-
-
Northcott, P.A.1
Korshunov, A.2
Witt, H.3
Hielscher, T.4
Eberhart, C.G.5
Mack, S.6
-
15
-
-
79954991010
-
Integrative genomic analysis of medulloblastoma identifies a molecular subgroup that drives poor clinical outcome
-
Cho YJ, Tsherniak A, Tamayo P, Santagata S, Ligon A, Greulich H, et al. Integrative genomic analysis of medulloblastoma identifies a molecular subgroup that drives poor clinical outcome. J Clin Oncol 2011;29:1424-30.
-
(2011)
J Clin Oncol
, vol.29
, pp. 1424-1430
-
-
Cho, Y.J.1
Tsherniak, A.2
Tamayo, P.3
Santagata, S.4
Ligon, A.5
Greulich, H.6
-
16
-
-
33646362581
-
Genomics identifies medulloblastoma subgroups that are enriched for specific genetic alterations
-
Thompson MC, Fuller C, HoggTL, Dalton J, Finkelstein D, Lau CC, et al. Genomics identifies medulloblastoma subgroups that are enriched for specific genetic alterations. J Clin Oncol 2006;24:1924-31.
-
(2006)
J Clin Oncol
, vol.24
, pp. 1924-1931
-
-
Thompson, M.C.1
Fuller, C.2
Hogg, T.L.3
Dalton, J.4
Finkelstein, D.5
Lau, C.C.6
-
17
-
-
61349128532
-
Rembrandt: Helping personalized medicine become a reality through integrative translational research
-
Madhavan S, Zenklusen JC, Kotliarov Y, Sahni H, Fine HA, Buetow K. Rembrandt: helping personalized medicine become a reality through integrative translational research. Mol Cancer Res 2009;7: 157-67.
-
(2009)
Mol Cancer Res
, vol.7
, pp. 157-167
-
-
Madhavan, S.1
Zenklusen, J.C.2
Kotliarov, Y.3
Sahni, H.4
Fine, H.A.5
Buetow, K.6
-
18
-
-
54549108740
-
Comprehensive genomic characterization defines human glioblastoma genes and core pathways
-
The Cancer Genome Atlas Research Network
-
The Cancer Genome Atlas Research Network. Comprehensive genomic characterization defines human glioblastoma genes and core pathways. Nature 2008;455:1061-8.
-
(2008)
Nature
, vol.455
, pp. 1061-1068
-
-
-
19
-
-
73649123907
-
Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR, and NF1
-
Verhaak RG, Hoadley KA, Purdom E,WangV, Qi Y, Wilkerson MD, et al. Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR, and NF1. Cancer Cell 2010;17:98-110.
-
(2010)
Cancer Cell
, vol.17
, pp. 98-110
-
-
Verhaak, R.G.1
Hoadley, K.A.2
Purdom, E.3
Wang, V.4
Qi, Y.5
Wilkerson, M.D.6
-
20
-
-
84867052186
-
Clinical significance of tumor-associated inflammatory cells in metastatic neuroblastoma
-
Asgharzadeh S, Salo JA, Ji L, Oberthuer A, Fischer M, Berthold F, et al. Clinical significance of tumor-associated inflammatory cells in metastatic neuroblastoma. J Clin Oncol 2012;30:3525-32.
-
(2012)
J Clin Oncol
, vol.30
, pp. 3525-3532
-
-
Asgharzadeh, S.1
Salo, J.A.2
Ji, L.3
Oberthuer, A.4
Fischer, M.5
Berthold, F.6
-
21
-
-
53149149440
-
Use of the viral 2A peptide for bicistronic expression in transgenic mice
-
Trichas G, Begbie J, Srinivas S. Use of the viral 2A peptide for bicistronic expression in transgenic mice. BMC Biol 2008;6:40.
-
(2008)
BMC Biol
, vol.6
, pp. 40
-
-
Trichas, G.1
Begbie, J.2
Srinivas, S.3
-
22
-
-
84863393028
-
Molecular subgroups of medulloblastoma: An international meta-analysis of transcriptome, genetic aberrations, and clinical data of WNT, SHH, Group 3, and Group 4 medulloblastomas
-
Kool M, Korshunov A, Remke M, Jones DT, Schlanstein M, Northcott PA, et al. Molecular subgroups of medulloblastoma: an international meta-analysis of transcriptome, genetic aberrations, and clinical data of WNT, SHH, Group 3, and Group 4 medulloblastomas. Acta Neuropathol (Berl) 2012;123:473-84.
-
(2012)
Acta Neuropathol (Berl)
, vol.123
, pp. 473-484
-
-
Kool, M.1
Korshunov, A.2
Remke, M.3
Jones, D.T.4
Schlanstein, M.5
Northcott, P.A.6
-
23
-
-
84860821444
-
Molecular subgroups of medulloblastoma: The current consensus
-
Taylor MD, Northcott PA, Korshunov A, Remke M, Cho YJ, Clifford SC, et al. Molecular subgroups of medulloblastoma: the current consensus. Acta Neuropathol (Berl) 2012;123:465-72.
-
(2012)
Acta Neuropathol (Berl)
, vol.123
, pp. 465-472
-
-
Taylor, M.D.1
Northcott, P.A.2
Korshunov, A.3
Remke, M.4
Cho, Y.J.5
Clifford, S.C.6
-
24
-
-
78650029935
-
Effects of NYGGF4 knockdown on insulin sensitivity and mitochondrial function in 3T3-L1 adipocytes
-
Zhang CM, Zeng XQ, Zhang R, Ji CB, Tong ML, Chi X, et al. Effects of NYGGF4 knockdown on insulin sensitivity and mitochondrial function in 3T3-L1 adipocytes. J Bioenerg Biomembr 2010;42:433-9.
-
(2010)
J Bioenerg Biomembr
, vol.42
, pp. 433-439
-
-
Zhang, C.M.1
Zeng, X.Q.2
Zhang, R.3
Ji, C.B.4
Tong, M.L.5
Chi, X.6
-
25
-
-
77954426713
-
Overexpression of NYGGF4 (PID1) induces mitochondrial impairment in 3T3-L1 adipocytes
-
Zhao Y, Zhang C, Chen X, Gao C, Ji C, Chen F, et al. Overexpression of NYGGF4 (PID1) induces mitochondrial impairment in 3T3-L1 adipocytes. Mol Cell Biochem 2010;340:41-8.
-
(2010)
Mol Cell Biochem
, vol.340
, pp. 41-48
-
-
Zhao, Y.1
Zhang, C.2
Chen, X.3
Gao, C.4
Ji, C.5
Chen, F.6
-
26
-
-
84869085503
-
Knockdown of NYGGF4 (PID1) rescues insulin resistance and mitochondrial dysfunction induced by FCCP in 3T3-L1 adipocytes
-
Shi CM, Wang YM, Zhang CM, Qiu J, Shen YH, Zhu JG, et al. Knockdown of NYGGF4 (PID1) rescues insulin resistance and mitochondrial dysfunction induced by FCCP in 3T3-L1 adipocytes. Mitochondrion 2012;12:600-6.
-
(2012)
Mitochondrion
, vol.12
, pp. 600-606
-
-
Shi, C.M.1
Wang, Y.M.2
Zhang, C.M.3
Qiu, J.4
Shen, Y.H.5
Zhu, J.G.6
-
27
-
-
84880950265
-
Overexpression of TFAM protects 3T3-L1 adipocytes from NYGGF4 (PID1) overexpression-induced insulin resistance and mitochondrial dysfunction
-
Shi CM, Xu GF, Yang L, Fu ZY, Chen L, Fu HL, et al. Overexpression of TFAM protects 3T3-L1 adipocytes from NYGGF4 (PID1) overexpression-induced insulin resistance and mitochondrial dysfunction. Cell Biochem Biophys 2013;66:489-97.
-
(2013)
Cell Biochem Biophys
, vol.66
, pp. 489-497
-
-
Shi, C.M.1
Xu, G.F.2
Yang, L.3
Fu, Z.Y.4
Chen, L.5
Fu, H.L.6
-
28
-
-
84883227182
-
PID1 induces insulin resistance in both human and mouse skeletal muscle during obesity
-
Bonala S, McFarlane C, Ang J, Lim R, Lee M, Chua H, et al. PID1 induces insulin resistance in both human and mouse skeletal muscle during obesity. Mol Endocrinol 2013;27:1518-35.
-
(2013)
Mol Endocrinol
, vol.27
, pp. 1518-1535
-
-
Bonala, S.1
McFarlane, C.2
Ang, J.3
Lim, R.4
Lee, M.5
Chua, H.6
-
29
-
-
64849098867
-
Overexpression of NYGGF4 inhibits glucose transport in 3T3-L1 adipocytes via attenuated phosphorylation of IRS-1 and Akt
-
Zhang CM, Chen XH, Wang B, Liu F, Chi X, Tong ML, et al. Overexpression of NYGGF4 inhibits glucose transport in 3T3-L1 adipocytes via attenuated phosphorylation of IRS-1 and Akt. Acta Pharmacol Sin 2009;30:120-4.
-
(2009)
Acta Pharmacol Sin
, vol.30
, pp. 120-124
-
-
Zhang, C.M.1
Chen, X.H.2
Wang, B.3
Liu, F.4
Chi, X.5
Tong, M.L.6
-
30
-
-
79851516706
-
Overexpression of NYGGF4 (PID1) inhibits glucose transport in skeletal myotubes by blocking the IRS1/PI3K/AKT insulin pathway
-
Wu WL, Gan WH, Tong ML, Li XL, Dai JZ, Zhang CM, et al. Overexpression of NYGGF4 (PID1) inhibits glucose transport in skeletal myotubes by blocking the IRS1/PI3K/AKT insulin pathway. Mol Genet Metab 2011;102:374-7.
-
(2011)
Mol Genet Metab
, vol.102
, pp. 374-377
-
-
Wu, W.L.1
Gan, W.H.2
Tong, M.L.3
Li, X.L.4
Dai, J.Z.5
Zhang, C.M.6
-
31
-
-
0023854380
-
Expression of two types of receptor for insulin-like growth factors in human malignant glioma
-
Gammeltoft S, Ballotti R, Kowalski A, Westermark B, Van Obberghen E. Expression of two types of receptor for insulin-like growth factors in human malignant glioma. Cancer Res 1988;48:1233-7.
-
(1988)
Cancer Res
, vol.48
, pp. 1233-1237
-
-
Gammeltoft, S.1
Ballotti, R.2
Kowalski, A.3
Westermark, B.4
Van Obberghen, E.5
-
32
-
-
0034665975
-
Patched target Igf2 is indispensable for the formation of medulloblastoma and rhabdomyosarcoma
-
Hahn H, Wojnowski L, Specht K, Kappler R, Calzada-Wack J, Potter D, et al. Patched target Igf2 is indispensable for the formation of medulloblastoma and rhabdomyosarcoma. J Biol Chem 2000;275: 28341-4.
-
(2000)
J Biol Chem
, vol.275
, pp. 28341-28344
-
-
Hahn, H.1
Wojnowski, L.2
Specht, K.3
Kappler, R.4
Calzada-Wack, J.5
Potter, D.6
-
33
-
-
0035963298
-
Activation of the IGF-IR system contributes to malignant growth of human and mouse medulloblastomas
-
Wang JY, Del Valle L, Gordon J, Rubini M, Romano G, Croul S, et al. Activation of the IGF-IR system contributes to malignant growth of human and mouse medulloblastomas. Oncogene 2001;20:3857-68.
-
(2001)
Oncogene
, vol.20
, pp. 3857-3868
-
-
Wang, J.Y.1
Del Valle, L.2
Gordon, J.3
Rubini, M.4
Romano, G.5
Croul, S.6
-
34
-
-
0034766126
-
Growth hormone and insulin-like growth factor-I: Effects on the growth of glioma cell lines
-
Friend KE, Khandwala HM, Flyvbjerg A, Hill H, Li J, McCutcheon IE. Growth hormone and insulin-like growth factor-I: effects on the growth of glioma cell lines. Growth Horm IGF Res 2001;11:84-91.
-
(2001)
Growth Horm IGF Res
, vol.11
, pp. 84-91
-
-
Friend, K.E.1
Khandwala, H.M.2
Flyvbjerg, A.3
Hill, H.4
Li, J.5
McCutcheon, I.E.6
-
35
-
-
0036278440
-
Insulinlike growth factor i receptor activity in human medulloblastomas
-
Del Valle L, Enam S, Lassak A, Wang JY, Croul S, Khalili K, et al. Insulinlike growth factor I receptor activity in human medulloblastomas. Clin Cancer Res 2002;8:1822-30.
-
(2002)
Clin Cancer Res
, vol.8
, pp. 1822-1830
-
-
Del Valle, L.1
Enam, S.2
Lassak, A.3
Wang, J.Y.4
Croul, S.5
Khalili, K.6
-
36
-
-
4444273153
-
Sonic hedgehog and insulin-like growth factor signaling synergize to induce medulloblastoma formation from nestin-expressing neural progenitors in mice
-
Rao G, Pedone CA, Del Valle L, Reiss K, Holland EC, Fults DW. Sonic hedgehog and insulin-like growth factor signaling synergize to induce medulloblastoma formation from nestin-expressing neural progenitors in mice. Oncogene 2004;23:6156-62.
-
(2004)
Oncogene
, vol.23
, pp. 6156-6162
-
-
Rao, G.1
Pedone, C.A.2
Del Valle, L.3
Reiss, K.4
Holland, E.C.5
Fults, D.W.6
-
37
-
-
20244370527
-
Insulinlike growth factor II is involved in the proliferation control of medulloblastoma and its cerebellar precursor cells
-
Hartmann W, Koch A, Brune H, Waha A, Schuller U, Dani I, et al. Insulinlike growth factor II is involved in the proliferation control of medulloblastoma and its cerebellar precursor cells. Am J Pathol 2005;166: 1153-62.
-
(2005)
Am J Pathol
, vol.166
, pp. 1153-1162
-
-
Hartmann, W.1
Koch, A.2
Brune, H.3
Waha, A.4
Schuller, U.5
Dani, I.6
-
38
-
-
34248136479
-
Inhibition of both focal adhesion kinase and insulin-like growth factor-I receptor kinase suppresses glioma proliferation in vitro and in vivo
-
Liu TJ, LaFortune T, Honda T, Ohmori O, Hatakeyama S, Meyer T, et al. Inhibition of both focal adhesion kinase and insulin-like growth factor-I receptor kinase suppresses glioma proliferation in vitro and in vivo. Mol Cancer Ther 2007;6:1357-67.
-
(2007)
Mol Cancer Ther
, vol.6
, pp. 1357-1367
-
-
Liu, T.J.1
Lafortune, T.2
Honda, T.3
Ohmori, O.4
Hatakeyama, S.5
Meyer, T.6
-
39
-
-
55349146248
-
Insulin-like growth factor 2 is required for progression to advanced medulloblastoma in patched1 heterozygous mice
-
Corcoran RB, Bachar Raveh T, Barakat MT, Lee EY, Scott MP. Insulin-like growth factor 2 is required for progression to advanced medulloblastoma in patched1 heterozygous mice. Cancer Res 2008;68:8788-95.
-
(2008)
Cancer Res
, vol.68
, pp. 8788-8795
-
-
Corcoran, R.B.1
Bachar Raveh, T.2
Barakat, M.T.3
Lee, E.Y.4
Scott, M.P.5
-
40
-
-
79251492356
-
Hedgehog/GLI1 regulates IGF dependent malignant behaviors in glioma stem cells
-
Hsieh A, Ellsworth R, Hsieh D. Hedgehog/GLI1 regulates IGF dependent malignant behaviors in glioma stem cells. J Cell Physiol 2011; 226:1118-27.
-
(2011)
J Cell Physiol
, vol.226
, pp. 1118-1127
-
-
Hsieh, A.1
Ellsworth, R.2
Hsieh, D.3
-
41
-
-
78651330430
-
COSMIC: Mining complete cancer genomes in the catalogue of somatic mutations in cancer
-
Forbes SA, Bindal N, Bamford S, Cole C, Kok CY, Beare D, et al. COSMIC: mining complete cancer genomes in the catalogue of somatic mutations in cancer. Nucleic Acids Res 2011;39:D945-50. Stroke
-
(2011)
Nucleic Acids Res
, vol.39
-
-
Forbes, S.A.1
Bindal, N.2
Bamford, S.3
Cole, C.4
Kok, C.Y.5
Beare, D.6
|